Mumbai, Oct. 24 -- Kilitch Drugs (India) announced it's a strategic divestment of its entire shareholding in its Ethiopian subsidiary, Kilitch Estro Biotech PLC (KEB), to HarmeeCare Pharmaceuticals, an Ethiopian state-owned enterprise, in a transaction valued at USS14 million.

Published by HT Digital Content Services with permission from Capital Market....